Ira Liran

Director Ira Liran sold 148,074 shares for $11,891,372.86 under 10b5-1 plan; holds 402,579 shares post-sale.

Ira Liran, a Director at Vita Coco Company, executed two separate sales totaling 148,074 shares for $11,891,372.86 at a blended average price of $80.31 on 2026-06-12. This sale reduced his holdings by 26.9% from 550,653 to 402,579 shares. The transaction is scheduled under a pre-arranged 10b5-1 trading plan, meaning it is not discretionary. The current price of $82.85 lies 0.2% from the 52-week high of $83.00, and the stock has appreciated 5.6% over the prior 30 days and 42.5% over 90 days. Liran's prior sales at COCO show mixed near-term outcomes (30-day returns ranged from -8.7% to +6.2%), though longer-term performance (90-day returns of +7.3% to +21.2%) has been generally positive. The company's fundamentals remain strong with $179.8M quarterly revenue, positive net income of $30.5M, and 18.2% annual revenue growth, though the P/E of 57.14 reflects elevated valuation.

Director Ira Liran sells 191,926 shares for $15,189,023.64 under 10b5-1 plan; reduces stake 28.7%

Ira Liran executed 2 separate sales totaling 191,926 shares for $15,189,023.64 at a blended average price of $79.14 per share on 2026-06-11, reducing his holdings from 668,347 to 476,421 shares—a -28.7% reduction. The transaction is part of a pre-arranged 10b5-1 trading plan, meaning it is scheduled rather than discretionary. The current price of $80.90 stands at -1.7% from the 52-week high of $82.33, with the stock up 8.2% over 30 days and 38.6% over 90 days. In his prior 5 trades at COCO, Liran's sales have shown mixed post-transaction performance, with two sales on 2026-02-05 followed by -8.7% 30-day returns and two sales on 2025-11-24 followed by +6.2% 30-day returns. The fundamentals show strong growth with 18.2% annual revenue increase, though the elevated P/E of 55.79 reflects current valuation context. As a scheduled 10b5-1 execution, this sale reflects contractual obligation rather than a discretionary market timing decision by the director.

Director Liran Ira sold 50,000 shares of COCO for $2,832,700.00 (avg $56.65) on 2026-02-05; stock at $58.96 (+0.0% from 52-week high).

Liran Ira, a Director, executed 2 separate sales totaling 50,000 shares for $2,832,700.00 at an average price of $56.65, reducing his holdings by 8.0% to 572,579 shares. The sales occurred near the 52-week high ($58.96 current, +0.0% from high), but follow a pattern at COCO where his prior 5 trades showed mixed near-term returns: his most recent measurable same-ticker sale (2025-11-05) posted a 90-day return of +39.0%, meaning the stock rose after his sale. His cross-ticker track record shows 20 prior sells with an average 90-day return of +15.9%, indicating a 31.25% well-timed rate overall. At COCO specifically, 0 of 1 prior measurable sells were well-timed at the 90-day mark. The company trades at a P/E of 48.73 with recent quarterly revenue of $182,313,000.00 and net income of $24,003,000.00; annual revenue growth is +4.5%.

Director Liran Ira sold 59,243 shares (59.2K shares) at $50.28 blended price for $2,978,788.61 ($3.0M), reducing holdings 9.0%.

Liran Ira, a director at Vita Coco, executed two separate sales totaling 59,243 shares (59.2K shares) for $2,978,788.61 ($3.0M) at a blended average price of $50.28 on 2025-11-24, trimming his post-transaction holdings to 602,579 shares (602.6K shares), a 9.0% reduction from his pre-transaction position. The sales occur as COCO's stock stands at $53.03, near its 52-week high of $53.03, having appreciated 33.7% over 30 days and 53.0% over 90 days. Vita Coco's fundamentals show trailing-twelve-month revenue of $182,313,000.00 ($182.3M), net income of $24,003,000.00 ($24.0M), and a P/E of 43.83, suggesting valuation has expanded significantly during the recent rally. This sale follows a pattern of five prior sales at COCO within the past month (on 2025-11-17, 2025-11-05, and 2025-10-29), indicating a sustained program of share reduction by this insider during a period of strong stock appreciation.

Director Liran Ira sold 40,757 shares for $2,041,589.01 at blended average $50.09 on 2025-11-17; holdings now 636,441 shares

Liran Ira executed 2 separate sales totaling 40,757 shares (40.8K shares) for $2,041,589.01 ($2.0M) at a blended average price of $50.09, reducing his holdings from 677,198 to 636,441 shares (-6.0% reduction). The transaction occurred at prices ($50.10 and $50.09) notably above the current market price of $47.29, and well above the 52-week range bottom of $27.00. Across his cross-ticker open-market history, Ira has 19 prior sells with a 90-day well-timed rate of 53.85%; however, his 5 prior trades at COCO show no completed 90-day measurement periods yet, making it premature to assess this sale's timing relative to his performance at this specific ticker. At the reporting date, the stock was near its 52-week high, up 13.6% over 30 days and 31.3% over 90 days.

Vita Coco Director Liran Ira sold 50,000 shares for $2.1M on 2025-11-05 at blended average $41.41; retains 662,579 shares.

Director Liran Ira executed 2 separate sales on 2025-11-05, totaling 50,000 shares for $2,070,290.00, reducing his holding by 7.0% from 712,579 to 662,579 shares. The sales occurred at $41.40 and $41.41, slightly below the current price of $42.11 and near the 52-week high of $45.28. His prior trades at COCO show mixed results: recent sells on 2025-10-29, 2025-09-17, and 2025-09-12 have limited measurable outcomes, and his cross-ticker track record reflects an average 90-day return of +1.5% after sells with a 58.33% well-timed rate. The execution of a substantial sale while the stock trades within recent highs, combined with his pattern of frequent sales at COCO over the past three months, reflects liquidity or portfolio activity without clear conviction signals from price action or historical outcomes at this ticker.

Director Liran Ira sold 40.0K shares of COCO at $45.58 for $1.8M, retaining 558.3K shares; stock down 9.0% from 52-week high.

Director Liran Ira sold 40,000 shares at $45.58 on 2025-10-29, representing a 6.7% reduction in his 598.3K-share position. The transaction occurred near the stock's 52-week high of $45.28, just prior to a subsequent 9.0% decline from that peak to the current price of $41.18. Across his cross-ticker track record, Ira's prior 16 sells averaged -4.6% over 30 days and +1.5% over 90 days, with a 58.33% well-timed rate, indicating mixed execution relative to market timing. At COCO specifically, his prior trades show sporadic results: his 2024-12-19 sale exhibited a -1.2% return at the 90-day mark (the only measurable longer-term outcome in his COCO history), while recent September and August sells have not yet reached their 90-day measurement window. The sale retains substantial insider holdings (558.3K shares remain), suggesting continuedposition retention rather than a complete exit.

Director Liran Ira sold 50,000 shares of COCO at $42.00 on 2025-09-17 for $2,100,150.00, reducing stake to 692,579 shares.

Liran Ira sold 50,000 shares (a 6.7% reduction of pre-transaction holdings) at $42.00, near the 52-week high of $42.30. The timing aligns with Vita Coco's strong recent momentum: the stock rose 10.6% over 30 days and 13.1% over 90 days preceding this sale. At COCO specifically, Ira's prior two measurable sales (2024-12-19 and 2024-06-18) both posted negative 90-day returns, and 2 of 2 prior sales were well-timed at the 90-day mark, suggesting this director has historically exited COCO before subsequent declines. The current price of $39.73 is 6.1% below the sale price, already showing post-transaction weakness. Against a P/E of 35.16 and annual revenue growth of 4.5%, this sale by a major shareholder (holding 692.6K shares post-trade) may reflect valuation concerns despite the company's profitable $22.9M net income last quarter.

Director Liran Ira sold 60,000 shares at $40.00–$40.01 on 2025-09-12, reducing holdings by 7.5% to 742,579 shares ($2.4M)

Liran Ira executed 2 separate sales totaling 60,000 shares for $2,400,280.00 at prices near the 52-week high of $40.30, coinciding with a 20.9% 30-day rally. His same-ticker history at COCO shows 3 of 4 prior sales were well-timed at the 90-day mark, a pattern continued here: he sold into strength after the stock rose sharply over the prior month. Post-transaction holdings of 742,579 shares remain substantial, with no liquidation signal. The sale timing aligns with the stock's proximity to its 52-week high, consistent with his historical pattern of sales following price advances.

Director Liran Ira sold 30,000 shares of COCO at $36.08 on 2025-08-20 for $1.1M, reducing stake from 812.6K to 782.6K shares

Liran Ira, a director at Vita Coco, executed an open-market sale of 30,000 shares at $36.08, reducing his post-transaction holdings to 782.6K shares (a 3.7% decrease from prior holdings of 812.6K shares). At the sale price of $36.08, shares now trade at $36.73, reflecting the current price is -0.65 below the transaction price and the stock is -8.9% from its 52-week high of $40.30. Across his same-ticker history at COCO, Liran has executed 5 prior sales; notably, 3 of those 5 prior sells were well-timed at the 90-day mark, indicating a pattern of selling into weakness on this specific name. His cross-ticker track record shows an average 90-day well-timed rate of 58.33%, suggesting a modest historical success at identifying selling windows, though the most recent same-ticker sales show mixed timing—two June 2024 sales saw 90-day declines of -7.0%, while two March 2024 sales saw 90-day gains of +16.0% and +19.5%. The company's fundamentals remain solid with $168.8M in latest quarterly revenue, $22.9M net income, and annual revenue growth of +4.5%, though the P/E of 32.50 reflects a relatively premium valuation.